- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
8 result(s) found for: Nucleoside transporter.
Displaying page 1 of 1.
| EudraCT Number: 2006-006076-38 | Sponsor Protocol Number: RLBUHT3173 | Start Date*: 2007-04-26 |
| Sponsor Name:University of Liverpool [...] | ||
| Full Title: The Liverpool HIV TDM Registry: Studying influences upon plasma HIV drug exposure | ||
| Medical condition: Pharmacogenetic study of HIV+ patients receiving antiretroviral therapy. We wish to correlate drug concentration with host genetic patients receiving certain HIV drugs. No dosage modification wil... | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-003425-81 | Sponsor Protocol Number: RLBUHT2763 | Start Date*: 2007-03-29 |
| Sponsor Name:University of Liverpool | ||
| Full Title: Host genetic factors influencing drug disposition and response to HIV treatment | ||
| Medical condition: Pharmacogeneric study of HIV+ patients receiving antiretroviral therapy. We wish to correlate drug concentration with host genetic patients receiving certain HIV drugs. No dosage modification will... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-007476-42 | Sponsor Protocol Number: CP4126-201 | Start Date*: 2009-01-09 |
| Sponsor Name:Clavis Pharma ASA | ||
| Full Title: A phase II study of CP-4126 in patients with advanced pancreatic cancer | ||
| Medical condition: Pancreatic Cancer | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Prematurely Ended) BE (Completed) FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-018240-23 | Sponsor Protocol Number: CO-101-001 | Start Date*: 2010-07-12 | |||||||||||
| Sponsor Name:Clovis Oncology Inc | |||||||||||||
| Full Title: A phase II Randomized, Open-Label, Multicenter Study Comparing CO-1.01 With Gemcitabine as First-Line Therapy in Patients with Metastatic Pancreatic Adenocarcinoma | |||||||||||||
| Medical condition: Metastatic pancreatic cancer | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) NO (Completed) FR (Completed) GB (Completed) SE (Completed) DE (Completed) IT (Prematurely Ended) NL (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2016-003287-39 | Sponsor Protocol Number: PRO-105 | Start Date*: 2017-07-05 |
| Sponsor Name:NuCana plc | ||
| Full Title: A Phase II Open-Label Study of NUC-1031 in Patients with Platinum-Resistant Ovarian Cancer | ||
| Medical condition: Platinum-resistant epithelial cancer of the ovary, fallopian tube or primary peritoneum (here termed ‘ovarian cancer’), who have been treated with 3 or more prior chemotherapy regimens. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-000363-24 | Sponsor Protocol Number: Met-Dipy001 | Start Date*: 2012-04-18 | ||||||||||||||||
| Sponsor Name:Radboud University Medical Centre Nijmegen | ||||||||||||||||||
| Full Title: The effect of dipyridamole on the pharmacokinetics of metformin. | ||||||||||||||||||
| Medical condition: The antihyperglycemic drug metformin and the thrombocyte aggregation inhibitor dipyridamole are often used concomitantly in patients with diabetes who have suffered a transient ischemic attack or s... | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: NL (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2008-006209-17 | Sponsor Protocol Number: I2I-MC-JMMC | Start Date*: 2011-07-05 |
| Sponsor Name:Eli Lilly and Company | ||
| Full Title: A Phase 1/Randomized Phase 2 Study to Evaluate LY2603618 in Combination with Gemcitabine in Patients with Pancreatic Cancer | ||
| Medical condition: Phase I: Patients with solid malignancy unlikely to benefit from approved therapies. Phase II: Patients with pancreatic cancer. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) SK (Completed) PL (Completed) IT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2008-008518-38 | Sponsor Protocol Number: CP4055-205 | Start Date*: 2009-09-30 |
| Sponsor Name:Clavis Pharma ASA | ||
| Full Title: A Phase II Study of Elacytarabine plus Idarubicin as Second Course Remission-Induction Therapy in Patients with Acute Myeloid Leukaemia | ||
| Medical condition: Acute Myeloid Leukaemia (AML) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) FR (Ongoing) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
